MedPath

Columbia University

Columbia University logo
🇺🇸United States
Ownership
Private
Established
1754-01-01
Employees
20.8K
Market Cap
-
Website
https://www.arch.columbia.edu

Role of B2 Adrenergic Receptors in Labor Pain

Completed
Conditions
Pain
Labour Pain
Pain Threshold
First Posted Date
2006-10-09
Last Posted Date
2018-07-18
Lead Sponsor
Columbia University
Target Recruit Count
150
Registration Number
NCT00385294
Locations
🇺🇸

Columbia University, New York, New York, United States

Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure

Phase 2
Terminated
Conditions
Heart Failure, Congestive
Interventions
Device: LVAD alone
Biological: Intramyocardial injection of bone marrow mononuclear cells
Biological: Intramyocardial injection of CD34+ selected bone marrow mononuclear cells
First Posted Date
2006-10-03
Last Posted Date
2019-04-17
Lead Sponsor
Columbia University
Target Recruit Count
1
Registration Number
NCT00383630
Locations
🇺🇸

Advocate Christ Medical Center, Oak Lawn, Illinois, United States

🇺🇸

Jewish Hospital, Louisville, Kentucky, United States

🇺🇸

Columbia University, New York, New York, United States

and more 4 locations

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2
Completed
Conditions
Lymphoma
Neurotoxicity
Peripheral Neuropathy
Sarcoma
Kidney Cancer
Leukemia
Interventions
Drug: Glutamine
Other: Placebo
First Posted Date
2006-08-17
Last Posted Date
2016-09-09
Lead Sponsor
Columbia University
Target Recruit Count
56
Registration Number
NCT00365768
Locations
🇺🇸

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States

The Effects of Alendronate After Cure of Primary Hyperparathyroidism

Phase 4
Withdrawn
Conditions
Hyperparathyroidism
Interventions
First Posted Date
2006-08-02
Last Posted Date
2011-11-16
Lead Sponsor
Columbia University
Registration Number
NCT00359385
Locations
🇺🇸

CUMC, New York, New York, United States

Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis

Phase 2
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2006-07-24
Last Posted Date
2011-02-01
Lead Sponsor
Columbia University
Target Recruit Count
86
Registration Number
NCT00355576
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

🇺🇸

UMDNJ, New Brunswick, New Jersey, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 16 locations

The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study

Phase 1
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
First Posted Date
2006-05-29
Last Posted Date
2012-12-10
Lead Sponsor
Columbia University
Target Recruit Count
1
Registration Number
NCT00331279
Locations
🇺🇸

Center for Women's Reproductive Care, New York, New York, United States

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

Phase 2
Completed
Conditions
Liver Transplantation
Bone Resorption
Heart Transplantation
Interventions
Drug: Zoledronic acid
Drug: Alendronate
Other: Placebo Alendronate
Other: Placebo Zoledronic Acid
First Posted Date
2006-03-01
Last Posted Date
2018-08-16
Lead Sponsor
Columbia University
Target Recruit Count
111
Registration Number
NCT00297830
Locations
🇺🇸

Columbia University Medical Center, New York, New York, United States

A Pilot Study of Neurocysticercosis Treatment

Phase 3
Completed
Conditions
Neurocysticercosis
Interventions
Other: placebo
Drug: albendazole
First Posted Date
2006-01-30
Last Posted Date
2010-02-08
Lead Sponsor
Columbia University
Target Recruit Count
178
Registration Number
NCT00283699
Locations
🇪🇨

Baca Ortiz Children's Hospital, Av. Colon s/n y 6 de Diciembre, Quito, Ecuador

🇪🇨

Teodoro Maldonado Carbo Hospital, Av. 25 de Julio Vía Puerto Marítimo, Guayaquil, Ecuador

🇪🇨

Hospital Eugenio Espejo, Servicio de Neurología, Av. Colombia s/n, Quito, Ecuador

and more 2 locations

Randomized Trial of Telemedicine for Diabetes Care

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Other: usual care
Device: Telemedicine Unit (HTU)
First Posted Date
2006-01-04
Last Posted Date
2023-09-18
Lead Sponsor
Columbia University
Target Recruit Count
1665
Registration Number
NCT00271739
Locations
🇺🇸

Columbia University, New York, New York, United States

🇺🇸

SUNY Upstate Medical University, Syracuse, New York, United States

Leptin in Human Energy and Neuroendocrine Homeostasis

Not Applicable
Terminated
Conditions
Obesity
Weight Loss
Interventions
Drug: Subcutaneous Placebo
Drug: Leptin
First Posted Date
2005-12-15
Last Posted Date
2019-09-18
Lead Sponsor
Columbia University
Target Recruit Count
22
Registration Number
NCT00265980
Locations
🇺🇸

Columbia University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath